Literature DB >> 23997078

Autoimmune limbic encephalitis presenting as relapsing psychosis.

Sarah A Hopkins1, Kuven K Moodley, Dennis Chan.   

Abstract

A 34-year-old woman with a history of relapsing psychosis presented with a 15-month history of impassivity and social withdrawal associated with cognitive impairment. The subsequent recurrence of psychomotor agitation, auditory hallucinations and delusional thinking resulted in an emergency admission under psychiatric services. Initial investigations, including MRI of the brain and cerebrospinal fluid studies were unremarkable and she was treated for a primary psychiatric disorder. The diagnosis of autoimmune limbic encephalitis was established after further investigations revealed the presence of antibodies to the NR1 subunit of the N-Methyl-d-aspartate receptor (NMDAR). Immunotherapy resulted in rapid resolution of psychosis and marked improvement in cognitive and social function. This case underlines the importance of considering anti-NMDAR encephalitis within the differential diagnosis of psychosis associated with cognitive impairment even in those with an apparent previous psychiatric history and response to antipsychotics.

Entities:  

Mesh:

Year:  2013        PMID: 23997078      PMCID: PMC3762128          DOI: 10.1136/bcr-2013-010461

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  41 in total

1.  Spontaneous recovery from anti-NMDAR encephalitis.

Authors:  Amelia Evoli; Pietro Spinelli; Giovanni Frisullo; Paolo E Alboini; Serenella Servidei; Camillo Marra
Journal:  J Neurol       Date:  2012-03-03       Impact factor: 4.849

2.  NMDA receptor encephalitis--expanding the clinical spectrum.

Authors:  Uma Nath; Naomi Margaret Warren; Husam Ali
Journal:  BMJ Case Rep       Date:  2011-07-28

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  The clinical profile of right temporal lobe atrophy.

Authors:  Dennis Chan; Valerie Anderson; Yolande Pijnenburg; Jennifer Whitwell; Jo Barnes; Rachael Scahill; John M Stevens; Frederik Barkhof; Philip Scheltens; Martin N Rossor; Nick C Fox
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

Review 5.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

6.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

Review 7.  Neurological disorders in schizophrenia.

Authors:  Arman Danielyan; Henry A Nasrallah
Journal:  Psychiatr Clin North Am       Date:  2009-12

Review 8.  Semantic dementia: a unique clinicopathological syndrome.

Authors:  John R Hodges; Karalyn Patterson
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

9.  Disease-relevant autoantibodies in first episode schizophrenia.

Authors:  Michael S Zandi; Sarosh R Irani; Bethan Lang; Patrick Waters; Peter B Jones; Peter McKenna; Alasdair J Coles; Angela Vincent; Belinda R Lennox
Journal:  J Neurol       Date:  2010-10-26       Impact factor: 4.849

10.  Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Authors:  Ko Tsutsui; Takashi Kanbayashi; Keiko Tanaka; Shuken Boku; Wakako Ito; Jun Tokunaga; Akane Mori; Yasuo Hishikawa; Tetsuo Shimizu; Seiji Nishino
Journal:  BMC Psychiatry       Date:  2012-05-08       Impact factor: 3.630

View more
  2 in total

1.  Olanzapine and Lorazepam Used in the Symptomatic Management of Excited Catatonia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Authors:  Namita Neerukonda; Michael Bliss; Abtin Jafroodifar; Luba Leontieva
Journal:  Cureus       Date:  2020-06-18

Review 2.  Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Detailed Review of the Different Psychiatric Presentations and Red Flags to Look for in Suspected Cases.

Authors:  Ghasaq K Subeh; Mehreen Lajber; Talha Patel; Jihan A Mostafa
Journal:  Cureus       Date:  2021-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.